INTERNATIONAL PATENT: BECTAS THERAPEUTICS, INC. FILES APPLICATION FOR "ANTIBODIES AGAINST LILRB4 AND LILRB2 AND USES THEREOF"

GENEVA, Oct. 6 -- BECTAS THERAPEUTICS, INC. (3262 Westheimer Road, #762Houston, TX 77098) filed a patent application (PCT/US2025/021367) for "ANTIBODIES AGAINST LILRB4 AND LILRB2 AND USES THEREOF" on Mar 25, 2025. With publication no. WO/2025/207653, the details related to the patent application was published on Oct 02, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): O'HAGAN, Ronan (3262 Westheimer Road, #762Houston, TX 77098)

Abstract: In certain aspects, the subject matter disclosed herein relates to high affinity monoclonal antibodies against LILRB4 and/or LILRB2 and their use in inhibit...